Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kaifeng Kangnuo Pharmaceutical is a specialized pharmaceutical manufacturer based in Kaifeng, China, focusing on steroid hormones and reproductive health products. The company is a leading producer of active pharmaceutical ingredients (APIs) and finished preparations, notably Mifepristone, Misoprostol, and Progesterone. Their facilities are GMP-certified, supporting a business model that includes both domestic sales and international exports. Kangnuo's portfolio primarily addresses clinical needs in gynecology, obstetrics, and family planning. The company maintains a strong emphasis on chemical synthesis and large-scale production of hormonal therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kaifeng Kangnuo Pharmaceutical.